CID 24765037

Pexmetinib

Structural Information

Molecular Formula
C31H33FN6O3
SMILES
CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NCC3=C(C=CC(=C3)F)OC4=CC5=C(C=C4)N(N=C5)CCO
InChI
InChI=1S/C31H33FN6O3/c1-20-5-8-24(9-6-20)38-29(17-28(36-38)31(2,3)4)35-30(40)33-18-22-15-23(32)7-12-27(22)41-25-10-11-26-21(16-25)19-34-37(26)13-14-39/h5-12,15-17,19,39H,13-14,18H2,1-4H3,(H2,33,35,40)
InChIKey
LNMRSSIMGCDUTP-UHFFFAOYSA-N
Compound name
1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[[5-fluoro-2-[1-(2-hydroxyethyl)indazol-5-yl]oxyphenyl]methyl]urea
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

8
References

1232
Patents

556.2598 Da
Monoisotopic Mass

5.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 557.26708 237.6
[M+Na]+ 579.24902 249.6
[M+NH4]+ 574.29362 240.4
[M+K]+ 595.22296 246.9
[M-H]- 555.25252 241.7
[M+Na-2H]- 577.23447 244.2
[M]+ 556.25925 240.2
[M]- 556.26035 240.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe